Delivery Order SPE2DR25D1017-SPE2DR26F8ZDP
- Not listed
- The Defense Logistics Agency awarded a $15,243.87 delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination respiratory medication) in a 60-dose configuration. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as...
- The Defense Logistics Agency awarded a delivery order valued at $8,492.56 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination respiratory medication, with an ultimate completion date of November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $21,739.01 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication, with an ultimate completion date of August 25, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,046.46 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (a combination respiratory medication), with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 (a combination respiratory medication) in the amount of $9,582.39 with an ultimate completion date of September 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,753.67 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used in respiratory disease management. The contract is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Trelegy Ellipta 100-62.5-25 60S, a combination respiratory medication, with a ceiling value of $8,524.93. This firm fixed price delivery order, which is not set-aside designated, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count), with a ceiling value of $4,436.68 and an ultimate completion date of October 31, 2025. This non-set-aside, firm fixed-price delivery order represents a small-value pharmaceutical procurement under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication, with a ceiling value of $4,691.69. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award under the company's existing indefinite delivery contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, the vendor's headquarters,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 28, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 (a combination respiratory medication) in a 60-dose configuration. This non-set-aside, competitively awarded delivery order carries a ceiling value of $6,346.21 under a firm fixed-price contract structure, with an ultimate completion date of May 29, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F8ZDPDelivery Order
The Defense Logistics Agency awarded a $7,508.38 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (a combination respiratory medication), with an ultimate completion date of November 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The contract reflects AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement needs, with demonstrated capability to fulfill competitive federal requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 11/6/25 |